Source: Annual Congress 2005 - Clinical aspects of OSA II
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
E. Duygu, E. Durgun Duygu, C. Cuhadaroglu, S. Erdine (Istanbul, Turkey). Relation between obstructive sleep apnea and echocardiograhic findings in hypertensive patients on multi-drug therapy. Eur Respir J 2005; 26: Suppl. 49, 3631

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Guidelines 2013 Year: 2013 CPAP therapy in idiopathic pulmonary fibrosis patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Echocardiography findings in patients with obstructive sleep apnea syndrome Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders Year: 2020 Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Increased arterial stiffness in patients with obstructive sleep apnea: clinical implication Source: Sleep and Breathing Conference 2021 Year: 2021 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Cardiac echo indices in patients with obstructive sleep apnea and COPD Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Resistant arterial hypertension and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Prevalence of sleep apnea in patients with resistant hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Assessment of pulmonary hypertension with non invasive technique among patients with sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004 Glaucoma and ocular hypertension in obstructive sleep apnea patients Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007